• Français

Pharmacovigilance

Reporting Drugs Adverse Reactions

Pharmacovigilance is the monitoring, evaluation, prevention and management of the adverse effects risk resulting from the use of medicines. In Morocco, it is exercised permanently, before and after the marketing of medicines, and constitutes an essential element of the safety control of medicines.

Through the collection, recording and scientific evaluation of information related to adverse reactions associated with the use of our medicines, SOLUDIA MAGHREB participates in the protection of human health.

SOLUDIA MAGHREB pharmacovigilance unit is in contact with the health authorities, in particular the Moroccan Pharmacovigilance Centre (CMPV). This unit proposes measures to reduce any risks associated with the use of our medicines and promotes their proper use.

Pharmacovigilance unit SOLUDIA MAGHREB
email: pharmacovigilance@soludia.ma
Phone : +212 537 845 986/ +212 537 844 242
Fax : +212 537 845 987

Moroccan Pharmacovigilance Centre
Emergency phone : +212 5 37 68 64 64
Or Eco N° : 0801 000 180
Fax : +212 5 37 77 71 79

    Patient

    Last name*

    Age* (ans)

    First name*

    Height* (cm)

    City*

    Weight* (kg)

    Gender*

    Hospitalized due to adverse reaction*

    History*

    Drugs(s), suspected or not

    Speciality and presentation*

    INN (active substance)*

    Dosage and route of administration*

    Start date*

    If due, end date

    Indication*

    Adverse Event(s)

    Observed adverse reaction(s)*

    Date of occurence*

    Possible end date

    Development*

    Case Description

    The clinic, chronology of events, possible corrective treatment, differential diagnoses eliminated, recurrence of the disorder in case of a reintroduction of the related drug.

    If applicable, please attach any hospitalization or consultation report and/or any biological report related to the suspected effect.

    Case Description*

    Informant

    Full name*

    Phone*

    Profile*

    City*

    Email*

    Date*

    Our partners